BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 11720635)

  • 21. Effects of long-acting calcium channel antagonists on neurohumoral factors: comparison of nifedipine coat-core with amlodipine.
    Tsutamoto T; Tsutsui T; Maeda K; Hayashi M; Wada A; Ohnishi M; Fujii M; Ishii C
    J Cardiovasc Pharmacol; 2003 Jan; 41 Suppl 1():S77-81. PubMed ID: 12688402
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical pharmacology of nisoldipine coat core.
    Zannad F
    Am J Cardiol; 1995 Apr; 75(13):41E-45E. PubMed ID: 7726124
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Managing hypertension using combination therapy.
    Frank J
    Am Fam Physician; 2008 May; 77(9):1279-86. PubMed ID: 18540493
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Actions of nisoldipine in cardiovascular disease.
    Duncker DJ; Van Woerkens LJ; Serruys PW; Roelandt JR; Hugenholtz PG; Verdouw PD
    Can J Cardiol; 1989; 5(5):266-74. PubMed ID: 2667729
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pharmacology--new therapy. Calcium channel blockers: new aspects of therapeutic use of diltiazem].
    Beleslin DB; Prostran MS; Jovanović-Mićić D
    Srp Arh Celok Lek; 1992; 120(5-6):188-92. PubMed ID: 1465675
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of diuretics in the prevention of heart failure: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.
    Davis BR; Piller LB; Cutler JA; Furberg C; Dunn K; Franklin S; Goff D; Leenen F; Mohiuddin S; Papademetriou V; Proschan M; Ellsworth A; Golden J; Colon P; Crow R;
    Circulation; 2006 May; 113(18):2201-10. PubMed ID: 16651474
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Combination therapy in cardiovascular diseases other than hypertension].
    Clement D; Wimart MC; Thibout E
    J Hum Hypertens; 1995 Aug; 9 Suppl 4():S41-6. PubMed ID: 7674273
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Beneficial effects of combination therapy with angiotensin II receptor blocker and angiotensin-converting enzyme inhibitor on vascular endothelial function.
    Morimoto S; Maki K; Aota Y; Sakuma T; Iwasaka T
    Hypertens Res; 2008 Aug; 31(8):1603-10. PubMed ID: 18971536
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative haemodynamic effects of intravenous nisoldipine and hydralazine in congestive heart failure.
    Haitas B; Meyer TE; Angel ME; Reef E
    Br J Clin Pharmacol; 1990 Mar; 29(3):366-8. PubMed ID: 2310661
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy.
    Khan NA; McAlister FA; Campbell NR; Feldman RD; Rabkin S; Mahon J; Lewanczuk R; Zarnke KB; Hemmelgarn B; Lebel M; Levine M; Herbert C;
    Can J Cardiol; 2004 Jan; 20(1):41-54. PubMed ID: 14968142
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Usefulness of oral nisoldipine for stable angina pectoris. The Nisoldipine Multicenter Angina Study Group.
    Frishman WH; Heiman M
    Am J Cardiol; 1991 Oct; 68(10):1004-9. PubMed ID: 1927911
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Felodipine and isradipine: new calcium-channel-blocking agents for the treatment of hypertension.
    Walton T; Symes LR
    Clin Pharm; 1993 Apr; 12(4):261-75. PubMed ID: 8458178
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacological and therapeutic basis for combined administration of beta blockers and calcium channel blockers in the treatment of stable chronic angina.
    Spaulding C; Cabanes L; Weber S
    Br J Clin Pract Suppl; 1997 Apr; 88():17-22. PubMed ID: 9519503
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Are all antihypertensive drugs renoprotective?].
    Wolf S; Risler T
    Herz; 2004 May; 29(3):248-54. PubMed ID: 15167950
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiovascular events in elderly patients with isolated systolic hypertension. A subgroup analysis of treatment strategies in STOP-Hypertension-2.
    Ekbom T; Linjer E; Hedner T; Lanke J; De Faire U; Wester PO; Dahlöf B; Scherstén B
    Blood Press; 2004; 13(3):137-41. PubMed ID: 15223721
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The relevance of sympathetic activity in the pharmacological treatment of chronic stable angina.
    Singh BN
    Can J Cardiol; 1999 Mar; 15 Suppl A():15A-21A. PubMed ID: 10205252
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Additional antihypertensive effect of drugs in hypertensive subjects uncontrolled on diltiazem monotherapy: a randomized controlled trial using office and home blood pressure monitoring.
    Karotsis AK; Symeonidis A; Mastorantonakis SE; Stergiou GS;
    Clin Exp Hypertens; 2006 Oct; 28(7):655-62. PubMed ID: 17060064
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Differential therapy with calcium antagonists].
    Scholze JE
    Herz; 2003 Dec; 28(8):754-63. PubMed ID: 14689111
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Nisoldipine in comparison with long-term nitrates].
    Eber B; Schumacher M; Zweiker R; Pokan R; Klein W
    Acta Med Austriaca; 1992; 19(5):137-9. PubMed ID: 1298142
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antianginal and anti-ischemic efficacy of immediate-release nisoldipine in chronic stable angina pectoris.
    Glasser SP; Bittar N; Labreche DG; Singh B; Katz R; Schulman P
    Am J Cardiol; 1994 Jun; 73(16):1165-8. PubMed ID: 7911271
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.